-
Je něco špatně v tomto záznamu ?
First inter-laboratory study of a Supercritical Fluid Chromatography method for the determination of pharmaceutical impurities
A. Dispas, R. Marini, V. Desfontaine, JL. Veuthey, D. Kotoni, LG. Losacco, A. Clarke, C. Muscat Galea, D. Mangelings, BM. Jocher, EL. Regalado, K. Plachká, L. Nováková, B. Wuyts, I. François, M. Gray, AJ. Aubin, A. Tarafder, M. Cazes, C....
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu srovnávací studie, časopisecké články
- MeSH
- chromatografie kapalinová metody normy MeSH
- kontaminace léku prevence a kontrola MeSH
- mezinárodní spolupráce * MeSH
- reprodukovatelnost výsledků MeSH
- řízení kvality MeSH
- superkritická fluidní chromatografie metody normy MeSH
- Publikační typ
- časopisecké články MeSH
- srovnávací studie MeSH
Supercritical Fluid Chromatography (SFC) has known a strong regain of interest for the last 10 years, especially in the field of pharmaceutical analysis. Besides the development and validation of the SFC method in one individual laboratory, it is also important to demonstrate its applicability and transferability to various laboratories around the world. Therefore, an inter-laboratory study was conducted and published for the first time in SFC, to assess method reproducibility, and evaluate whether this chromatographic technique could become a reference method for quality control (QC) laboratories. This study involved 19 participating laboratories from 4 continents and 9 different countries. It included 5 academic groups, 3 demonstration laboratories at analytical instrument companies, 10 pharmaceutical companies and 1 food company. In the initial analysis of the study results, consistencies within- and between-laboratories were deeply examined. In the subsequent analysis, the method reproducibility was estimated taking into account variances in replicates, between-days and between-laboratories. The results obtained were compared with the literature values for liquid chromatography (LC) in the context of impurities determination. Repeatability and reproducibility variances were found to be similar or better than those described for LC methods, and highlighted the adequacy of the SFC method for QC analyses. The results demonstrated the excellent and robust quantitative performance of SFC. Consequently, this complementary technique is recognized on equal merit to other chromatographic techniques.
Cipla R and D centre Analytical development lab LBS Road Vikhroli Mumbai 400083 India
Merck and Co Inc Process Research and Development MRL Rahway NJ 07065 USA
Novartis Pharma AG Technical R and D Chemical and Analytical Development Basel CH4056 Switzerland
Oril Industries 13 rue Auguste Desgenetais 76210 Bolbec France
Pfizer Global R and D Analytical R and D Ramsgate Road Sandwich Kent CT13 9NJ United Kingdom
Sanofi R and D Analytical Sciences 13 Quai Jules Guesde 94400 Vitry sur Seine France
Sanofi R and D Analytical Sciences 371 Rue du Professeur Blayac 34080 Montpellier France
SERVIER Research Institute Analytical and Physical Chemistry Department France
University of Orléans ICOA CNRS UMR 7311 rue de Chartres BP 6759 45067 Orléans Cedex 2 France
Vrije Universiteit Brussel Laarbeeklaan 103 1090 Brussels Belgium
Waters Australia PTY LTD Australia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012380
- 003
- CZ-PrNML
- 005
- 20190405092756.0
- 007
- ta
- 008
- 190405s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jpba.2018.08.042 $2 doi
- 035 __
- $a (PubMed)30216790
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Dispas, Amandine $u University of Liège (ULiege), CIRM, Laboratory of Pharmaceutical Analytical Chemistry, CHU, Avenue Hippocrate 15, 4000 Liège, Belgium; University of Liège (ULiege), CIRM, Laboratory for the Analysis of Medicines, CHU, Avenue Hippocrate 15, 4000 Liège, Belgium. Electronic address: amandine.dispas@uliege.be.
- 245 10
- $a First inter-laboratory study of a Supercritical Fluid Chromatography method for the determination of pharmaceutical impurities / $c A. Dispas, R. Marini, V. Desfontaine, JL. Veuthey, D. Kotoni, LG. Losacco, A. Clarke, C. Muscat Galea, D. Mangelings, BM. Jocher, EL. Regalado, K. Plachká, L. Nováková, B. Wuyts, I. François, M. Gray, AJ. Aubin, A. Tarafder, M. Cazes, C. Desvignes, L. Villemet, M. Sarrut, A. Raimbault, E. Lemasson, E. Lesellier, C. West, T. Leek, M. Wong, L. Dai, K. Zhang, A. Grand-Guillaume Perrenoud, C. Brunelli, P. Hennig, S. Bertin, F. Mauge, N. Da Costa, WP. Farrell, M. Hill, N. Desphande, M. Grangrade, S. Sadaphule, R. Yadav, S. Rane, S. Shringare, M. Iguiniz, S. Heinisch, J. Lefevre, E. Corbel, N. Roques, YV. Heyden, D. Guillarme, P. Hubert,
- 520 9_
- $a Supercritical Fluid Chromatography (SFC) has known a strong regain of interest for the last 10 years, especially in the field of pharmaceutical analysis. Besides the development and validation of the SFC method in one individual laboratory, it is also important to demonstrate its applicability and transferability to various laboratories around the world. Therefore, an inter-laboratory study was conducted and published for the first time in SFC, to assess method reproducibility, and evaluate whether this chromatographic technique could become a reference method for quality control (QC) laboratories. This study involved 19 participating laboratories from 4 continents and 9 different countries. It included 5 academic groups, 3 demonstration laboratories at analytical instrument companies, 10 pharmaceutical companies and 1 food company. In the initial analysis of the study results, consistencies within- and between-laboratories were deeply examined. In the subsequent analysis, the method reproducibility was estimated taking into account variances in replicates, between-days and between-laboratories. The results obtained were compared with the literature values for liquid chromatography (LC) in the context of impurities determination. Repeatability and reproducibility variances were found to be similar or better than those described for LC methods, and highlighted the adequacy of the SFC method for QC analyses. The results demonstrated the excellent and robust quantitative performance of SFC. Consequently, this complementary technique is recognized on equal merit to other chromatographic techniques.
- 650 _2
- $a chromatografie kapalinová $x metody $x normy $7 D002853
- 650 _2
- $a superkritická fluidní chromatografie $x metody $x normy $7 D025924
- 650 _2
- $a kontaminace léku $x prevence a kontrola $7 D004340
- 650 12
- $a mezinárodní spolupráce $7 D007391
- 650 _2
- $a řízení kvality $7 D011786
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Marini, Roland $u University of Liège (ULiege), CIRM, Laboratory of Pharmaceutical Analytical Chemistry, CHU, Avenue Hippocrate 15, 4000 Liège, Belgium.
- 700 1_
- $a Desfontaine, Vincent $u University of Geneva, University of Lausanne, School of Pharmaceutical Sciences, CMU - Rue Michel Servet 1, 1211 Geneva 4, Switzerland.
- 700 1_
- $a Veuthey, Jean-Luc $u University of Geneva, University of Lausanne, School of Pharmaceutical Sciences, CMU - Rue Michel Servet 1, 1211 Geneva 4, Switzerland.
- 700 1_
- $a Kotoni, Dorina $u Novartis Pharma AG, Technical R&D, Chemical and Analytical Development, Basel, CH4056, Switzerland.
- 700 1_
- $a Losacco, Luca Gioacchino $u Novartis Pharma AG, Technical R&D, Chemical and Analytical Development, Basel, CH4056, Switzerland.
- 700 1_
- $a Clarke, Adrian $u Novartis Pharma AG, Technical R&D, Chemical and Analytical Development, Basel, CH4056, Switzerland.
- 700 1_
- $a Muscat Galea, Charlene $u Vrije Universiteit Brussel (VUB), Department of Analytical Chemistry, Applied Chemometrics and Molecular Modelling (FABI), Laarbeeklaan 103, 1090 Brussels, Belgium.
- 700 1_
- $a Mangelings, Debby $u Vrije Universiteit Brussel (VUB), Department of Analytical Chemistry, Applied Chemometrics and Molecular Modelling (FABI), Laarbeeklaan 103, 1090 Brussels, Belgium.
- 700 1_
- $a Jocher, Brandon M $u Merck & Co., Inc., Process Research and Development, MRL, Rahway, NJ, 07065 USA.
- 700 1_
- $a Regalado, Erik L $u Merck & Co., Inc., Process Research and Development, MRL, Rahway, NJ, 07065 USA.
- 700 1_
- $a Plachká, Katerina $u Charles University, Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Heyrovského 1203, 500 05, Hradec Králové, Czech Republic.
- 700 1_
- $a Nováková, Lucie $u Charles University, Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Heyrovského 1203, 500 05, Hradec Králové, Czech Republic.
- 700 1_
- $a Wuyts, Benjamin $u Waters SAS, 5 rue Jacques Monod, 78280, Guyancourt, France.
- 700 1_
- $a François, Isabelle $u Waters SAS, 5 rue Jacques Monod, 78280, Guyancourt, France.
- 700 1_
- $a Gray, Michael $u Waters Australia PTY LTD, Australia.
- 700 1_
- $a Aubin, Andrew J $u Waters Corporation, 34 Maple St., Milford, MA, 01757, USA.
- 700 1_
- $a Tarafder, Abhijit $u Waters Corporation, 34 Maple St., Milford, MA, 01757, USA.
- 700 1_
- $a Cazes, Maxime $u Sanofi R&D, Analytical Sciences, 371 Rue du Professeur Blayac, 34080, Montpellier, France.
- 700 1_
- $a Desvignes, Christophe $u Sanofi R&D, Analytical Sciences, 371 Rue du Professeur Blayac, 34080, Montpellier, France.
- 700 1_
- $a Villemet, Loic $u Sanofi R&D, Analytical Sciences, 371 Rue du Professeur Blayac, 34080, Montpellier, France.
- 700 1_
- $a Sarrut, Morgan $u Sanofi R&D, Analytical Sciences, 13 Quai Jules Guesde, 94400, Vitry-sur-Seine, France.
- 700 1_
- $a Raimbault, Adrien $u University of Orléans, ICOA, CNRS, UMR 7311, rue de Chartres, BP 6759, 45067 Orléans Cedex 2, France.
- 700 1_
- $a Lemasson, Elise $u University of Orléans, ICOA, CNRS, UMR 7311, rue de Chartres, BP 6759, 45067 Orléans Cedex 2, France.
- 700 1_
- $a Lesellier, Eric $u University of Orléans, ICOA, CNRS, UMR 7311, rue de Chartres, BP 6759, 45067 Orléans Cedex 2, France.
- 700 1_
- $a West, Caroline $u University of Orléans, ICOA, CNRS, UMR 7311, rue de Chartres, BP 6759, 45067 Orléans Cedex 2, France.
- 700 1_
- $a Leek, Tomas $u Medicinal Chemistry, Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca R&D, Gothenburg, Sweden.
- 700 1_
- $a Wong, Mengling $u Genentech, USA.
- 700 1_
- $a Dai, Lulu $u Genentech, USA.
- 700 1_
- $a Zhang, Kelly $u Genentech, USA.
- 700 1_
- $a Grand-Guillaume Perrenoud, Alexandre $u Nestlé Institute of Health Sciences, Natural Bioactives and Screening, EPFL Innovation Park, H, 1015, Lausanne, Switzerland.
- 700 1_
- $a Brunelli, Claudio $u Pfizer Global R & D, Analytical R&D, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom.
- 700 1_
- $a Hennig, Philippe $u SERVIER Research Institute, Analytical and Physical Chemistry Department, France.
- 700 1_
- $a Bertin, Sophie $u SERVIER Research Institute, Analytical and Physical Chemistry Department, France.
- 700 1_
- $a Mauge, Fabien $u SERVIER Research Institute, Analytical and Physical Chemistry Department, France.
- 700 1_
- $a Da Costa, Nathalie $u SERVIER Research Institute, Analytical and Physical Chemistry Department, France.
- 700 1_
- $a Farrell, William P $u Pfizer Worldwide Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, CA, 92121 USA.
- 700 1_
- $a Hill, Madeleine $u Pfizer Worldwide Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, CA, 92121 USA.
- 700 1_
- $a Desphande, Niranjan $u Cipla R&D centre, Analytical development lab, LBS Road, Vikhroli, Mumbai, 400083, India.
- 700 1_
- $a Grangrade, Manish $u Cipla R&D centre, Analytical development lab, LBS Road, Vikhroli, Mumbai, 400083, India.
- 700 1_
- $a Sadaphule, Santosh $u Cipla R&D centre, Analytical development lab, LBS Road, Vikhroli, Mumbai, 400083, India.
- 700 1_
- $a Yadav, Ravi $u Cipla R&D centre, Analytical development lab, LBS Road, Vikhroli, Mumbai, 400083, India.
- 700 1_
- $a Rane, Sandesh $u Cipla R&D centre, Analytical development lab, LBS Road, Vikhroli, Mumbai, 400083, India.
- 700 1_
- $a Shringare, Shankar $u Cipla R&D centre, Analytical development lab, LBS Road, Vikhroli, Mumbai, 400083, India.
- 700 1_
- $a Iguiniz, Marion $u Université de Lyon, Institut des Sciences Analytiques, UMR 5280, CNRS, Université Lyon 1, ENS Lyon, 5 rue de la Doua, 69100, Villeurbanne, France; Oril Industries, 13 rue Auguste Desgenetais, 76210, Bolbec, France.
- 700 1_
- $a Heinisch, Sabine $u Université de Lyon, Institut des Sciences Analytiques, UMR 5280, CNRS, Université Lyon 1, ENS Lyon, 5 rue de la Doua, 69100, Villeurbanne, France.
- 700 1_
- $a Lefevre, Julien $u Oril Industries, 13 rue Auguste Desgenetais, 76210, Bolbec, France.
- 700 1_
- $a Corbel, Estelle $u Oril Industries, 13 rue Auguste Desgenetais, 76210, Bolbec, France.
- 700 1_
- $a Roques, Nicolas $u Oril Industries, 13 rue Auguste Desgenetais, 76210, Bolbec, France.
- 700 1_
- $a Heyden, Yvan Vander $u Vrije Universiteit Brussel (VUB), Department of Analytical Chemistry, Applied Chemometrics and Molecular Modelling (FABI), Laarbeeklaan 103, 1090 Brussels, Belgium.
- 700 1_
- $a Guillarme, Davy $u University of Geneva, University of Lausanne, School of Pharmaceutical Sciences, CMU - Rue Michel Servet 1, 1211 Geneva 4, Switzerland.
- 700 1_
- $a Hubert, Philippe $u University of Liège (ULiege), CIRM, Laboratory of Pharmaceutical Analytical Chemistry, CHU, Avenue Hippocrate 15, 4000 Liège, Belgium.
- 773 0_
- $w MED00002894 $t Journal of pharmaceutical and biomedical analysis $x 1873-264X $g Roč. 161, č. - (2018), s. 414-424
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30216790 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190405092805 $b ABA008
- 999 __
- $a ok $b bmc $g 1391690 $s 1050685
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 161 $c - $d 414-424 $e 20180823 $i 1873-264X $m Journal of pharmaceutical and biomedical analysis $n J Pharm Biomed Anal $x MED00002894
- LZP __
- $a Pubmed-20190405
